Table 1 Correlation of common mutations with clinical and laboratory features in PNH.

From: Mutational landscape and its clinical significance in paroxysmal nocturnal hemoglobinuria

 

Age (year old, SD)

Sex (male %)

Classical PNH (%)

Patients with thrombosis (%)

FLAER- (%, SD)

UCB (μmol/L, SD)

HGB (g/L, SD)

RET (109/L, SD)

LDH (U/L, SD)

PIGA

Mutated

39 (12)

13***

50

50

90.6 (7.3)***

15.8 (10.0)

79.9 (15.1)

21.0 (12.6)

1311 (899)

Unmutated

39 (14)

85***

45

27

64.4 (32.1)***

17.4 (11.7)

81.2 (25.1)

30.5 (63.7)

1159 (734)

MAP3K4

Mutated

34 (14)

60

20

20

72.4 (35.4)

14.2 (13.2)

72.8 (18.8)

10.8 (10.8)

1189 (1057)

Unmutated

40 (15)

72

50

33

68.2 (30.6)

17.5 (11.1)

82.1 (23.9)

30.8 (60.8)

1189 (729)

CSMD1

Mutated

37 (19)

60

20

0

56.6 (42.9)

12.6 (8.8)

79.8 (27.1)

9.9 (6.8)

779 (565)

Unmutated

40 (14)

72

50

33

71.4 (29.0)

17.7 (11.5)

81.1 (23.2)

31.5 (61.6)

1246 (771)

NOTCH1

Mutated

41 (9)

50

75

50

63.0 (37.4)

9.8 (4.8)

94.5 (26.1)

15.0 (8.4)

787 (404)

Unmutated

39 (15)

73

43

30

70.3 (30.5)

17.8 (11.5)

79.5 (22.9)

30.3 (61.0)

1232 (779)

FANCD2

Mutated

37 (16)

20

25

25

67.7 (35.6)

11.1 (8.9)

72.5 (20.4)

18.8 (19.0)

1165 (1323)

Unmutated

40 (14)

76

49

32

69.8 (30.7)

17.7 (11.4)

81.9 (23.7)

29.9 (60.9)

1191 (703)

RUNX1T1

Mutated

36 (4)

100

75

25

92.8 (5.4)***

30.9 (16.2)**

55.5 (13.3)*

31.6 (30.4)

1301 (565)

Unmutated

40 (15)

68

43

32

67.0 (31.3)***

15.6 (9.8)**

83.7 (22.6)*

28.4 (60.5)

1177 (783)

PEG3

Mutated

50 (22)

75

0

25

59.5 (33.7)

16.7 (11.7)

81.3 (23.0)

54.6 (85.4)

1355 (1141)

Unmutated

38 (13)

70

51

32

70.6 (30.7)

17.1 (11.4)

81.0 (23.7)

25.8 (54.9)

1171 (727)

DIS3

Mutated

40 (19)

100

75

25

75.7 (15.0)

13.9 (6.7)

92.5 (34.3)

13.7 (10.1)

970 (502)

Unmutated

39 (14)

68

43

32

68.9 (32.0)

17.4 (11.7)

79.7 (22.2)

30.5 (60.9)

1212 (783)

BCORL1

         

Mutated

57 (19)**

50

0

25

53.2 (28.6)

17.9 (11.1)

65.3 (17.3)

53.8 (85.4)

1316 (1069)

Unmutated

37 (13)**

73

51

32

71.3 (30.8)

17.0 (11.4)

82.7 (23.5)

25.9 (55.0)

1175 (737)

SETBP1

Mutated

47 (13)

100

75

0

69.0 (35.7)

16.9 (8.9)

76.3 (28.2)

13.1 (10.4)

1050 (639)

Unmutated

38 (15)

68

43

35

69.6 (30.7)

17.1 (11.6)

81.5 (23.2)

30.6 (60.9)

1204 (777)

  1. Measurement data were presented as average (standard deviation).
  2. FLAER- proportion of fluorescent aerolysin-negative granulocytes, UCB unconjugated bilirubin, HGB hemoglobin, RET reticulocyte count, LDH lactic dehydrogenase.
  3. *p < 0.05, **p < 0.01, ***p < 0.001.